Unlock regulatory insights with Watson. Learn More
Return to Docket

Draft Guidance for Industry on Distributing Scientific and Medical Publications on Risk Information For Approved Prescription Drugs and Biological Products--Recommended Practices; Availability

Type: Non-Rule Making
Center CDER

Primary Documents (2)